ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
At Insmed, every moment and every patient counts — and so does every person who joins in. As a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases, you’ll be part of a community that prioritizes the human experience, celebrates curiosity, and values every person’s contributions to meaningful progress. That commitment has earned us recognition as Science magazine’s No.
The October edition of our People Pathways newsletter is now available to read here!
Featuring:
✅ Preview of One Nucleus 2026 courses
✅ One Nucleus Jobs Board - Helping the Industry
✅ Online Training in Python Programming, Data Science, Networks, Machine Learning & AI
and some useful information...
A new blog has been published by Amsbio comparing the benefits of its CELLBANKER® range of cryopreservation solutions with ‘homebrew’ cryopreservation media.
Homebrew cryopreservation media are do-it-yourself solutions, commonly using a mixture of DMSO, a serum (such as FBS), and a basal growth medium. These mixtures are often favored because of their lower upfront cost or to meet specific lab needs, but the optimal formulation depends heavily on the cell line's sensitivity.
Breast cancer continues to affect millions worldwide, not just as statistics, but as mothers, sisters, daughters, and friends. Its biological complexity and diverse subtypes make therapy development especially challenging, particularly for metastatic disease, the leading cause of breast cancer mortality.
BioDuro’s CDX (Cell-Derived Xenograft) model platform offers a comprehensive library of preclinical breast cancer models that reflect real-world tumor heterogeneity. These models enable researchers to:
Lir Therapeutics is a VC-backed biotech start-up that’s focused on unlocking the next generation of gene therapy using AI. Lir’s current work focuses on adeno-associated virus (AAV), one of the major gene therapy vectors in use.
Our current aim is to completely redesign AAV, in order to generate therapies that are more effective, safer, and cheaper. Lir is founded by scientists with experience building gene therapies and AI models for biology. Come join us and build a science-led biotech, right in central London!
Details of the role:
Reports to: Christelle Soudy - Principal Laboratory Research Scientist Medicinal Chemistry
Contact term: This is a full-time, permanent position on Crick terms and conditions of employment.
About us
3 Month Contract
Near Cambridge UK
Scientist / Bioanalytics, PK assays, MSD
Candidates will need to be available to start quickly, be able to be based in Cambridge, have right to work in the UK and have experience with the above techniques. Some training could be given to certain areas lacking.
Based at Alderley Park, Medicines Discovery Catapult is a national Life Sciences service dedicated to turning drug discovery into commercial breakthroughs. We accelerate the development of science, and where there are areas of unmet patient need, we stimulate innovation.